Literature DB >> 35810449

GRN Mutations Are Associated with Lewy Body Dementia.

Paolo Reho1, Shunsuke Koga2, Zalak Shah1, Ruth Chia3, Rosa Rademakers2,4, Clifton L Dalgard5,6, Bradley F Boeve7, Thomas G Beach8, Dennis W Dickson2, Owen A Ross2,9, Sonja W Scholz1,10.   

Abstract

BACKGROUND: Loss-of-function mutations in GRN are a cause of familial frontotemporal dementia, and common variants within the gene have been associated with an increased risk of developing Alzheimer's disease and Parkinson's disease. Although TDP-43-positive inclusions are characteristic of GRN-related neurodegeneration, Lewy body copathology has also been observed in many GRN mutation carriers.
OBJECTIVE: The objective of this study was to assess a Lewy body dementia (LBD) case-control cohort for pathogenic variants in GRN and to test whether there is an enrichment of damaging mutations among patients with LBD.
METHODS: We analyzed whole-genome sequencing data generated for 2591 European-ancestry LBD cases and 4032 neurologically healthy control subjects to identify disease-causing mutations in GRN.
RESULTS: We identified six heterozygous exonic GRN mutations in seven study participants (cases: n = 6; control subjects: n = 1). Each variant was predicted to be pathogenic or likely pathogenic. We found significant enrichment of GRN loss-of-function mutations in patients with LBD compared with control subjects (Optimized Sequence Kernel Association Test P = 0.0162). Immunohistochemistry in three definite LBD cases demonstrated Lewy body pathology and TDP-43-positive neuronal inclusions.
CONCLUSIONS: Our findings suggest that deleterious GRN mutations are a rare cause of familial LBD.
© 2022 International Parkinson Movement Disorder Society. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA. © 2022 International Parkinson Movement Disorder Society. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.

Entities:  

Keywords:  zzm321990GRN mutations; Lewy body dementia (LBD); frontotemporal lobar degeneration (FTLD); neurodegeneration; progranulin

Mesh:

Substances:

Year:  2022        PMID: 35810449      PMCID: PMC9474656          DOI: 10.1002/mds.29144

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   9.698


  29 in total

1.  A mutant PSEN1 causes dementia with Lewy bodies and variant Alzheimer's disease.

Authors:  Atsushi Ishikawa; Yue-Shan Piao; Akinori Miyashita; Ryozo Kuwano; Osamu Onodera; Hiroaki Ohtake; Masahiro Suzuki; Masatoyo Nishizawa; Hitoshi Takahashi
Journal:  Ann Neurol       Date:  2005-03       Impact factor: 10.422

2.  Prominent phenotypic variability associated with mutations in Progranulin.

Authors:  Brendan J Kelley; Wael Haidar; Bradley F Boeve; Matt Baker; Neill R Graff-Radford; Thomas Krefft; Andrew R Frank; Clifford R Jack; Maria Shiung; David S Knopman; Keith A Josephs; Sotirios A Parashos; Rosa Rademakers; Mike Hutton; Stuart Pickering-Brown; Jennifer Adamson; Karen M Kuntz; Dennis W Dickson; Joseph E Parisi; Glenn E Smith; Robert J Ivnik; Ronald C Petersen
Journal:  Neurobiol Aging       Date:  2007-10-18       Impact factor: 4.673

3.  HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin.

Authors:  Odity Mukherjee; Pau Pastor; Nigel J Cairns; Sumi Chakraverty; John S K Kauwe; Shantia Shears; Maria I Behrens; John Budde; Anthony L Hinrichs; Joanne Norton; Denise Levitch; Lisa Taylor-Reinwald; Michael Gitcho; P-H Tu; Lea Tenenholz Grinberg; Rajka M Liscic; Javier Armendariz; John C Morris; Alison M Goate
Journal:  Ann Neurol       Date:  2006-09       Impact factor: 10.422

4.  Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family.

Authors:  Nathalie Brouwers; Karen Nuytemans; Julie van der Zee; Ilse Gijselinck; Sebastiaan Engelborghs; Jessie Theuns; Samir Kumar-Singh; Barbara A Pickut; Philippe Pals; Bart Dermaut; Veerle Bogaerts; Tim De Pooter; Sally Serneels; Marleen Van den Broeck; Ivy Cuijt; Maria Mattheijssens; Karin Peeters; Raf Sciot; Jean-Jacques Martin; Patrick Cras; Patrick Santens; Rik Vandenberghe; Peter P De Deyn; Marc Cruts; Christine Van Broeckhoven; Kristel Sleegers
Journal:  Arch Neurol       Date:  2007-10

5.  Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study.

Authors:  Isabelle Le Ber; Agnès Camuzat; Didier Hannequin; Florence Pasquier; Eric Guedj; Anne Rovelet-Lecrux; Valérie Hahn-Barma; Julie van der Zee; Fabienne Clot; Serge Bakchine; Michèle Puel; Mustapha Ghanim; Lucette Lacomblez; Jacqueline Mikol; Vincent Deramecourt; Pascal Lejeune; Vincent de la Sayette; Serge Belliard; Martine Vercelletto; Christian Meyrignac; Christine Van Broeckhoven; Jean-Charles Lambert; Patrice Verpillat; Dominique Campion; Marie-Odile Habert; Bruno Dubois; Alexis Brice
Journal:  Brain       Date:  2008-02-01       Impact factor: 13.501

6.  Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.

Authors:  Mike A Nalls; Cornelis Blauwendraat; Costanza L Vallerga; Karl Heilbron; Sara Bandres-Ciga; Diana Chang; Manuela Tan; Demis A Kia; Alastair J Noyce; Angli Xue; Jose Bras; Emily Young; Rainer von Coelln; Javier Simón-Sánchez; Claudia Schulte; Manu Sharma; Lynne Krohn; Lasse Pihlstrøm; Ari Siitonen; Hirotaka Iwaki; Hampton Leonard; Faraz Faghri; J Raphael Gibbs; Dena G Hernandez; Sonja W Scholz; Juan A Botia; Maria Martinez; Jean-Christophe Corvol; Suzanne Lesage; Joseph Jankovic; Lisa M Shulman; Margaret Sutherland; Pentti Tienari; Kari Majamaa; Mathias Toft; Ole A Andreassen; Tushar Bangale; Alexis Brice; Jian Yang; Ziv Gan-Or; Thomas Gasser; Peter Heutink; Joshua M Shulman; Nicholas W Wood; David A Hinds; John A Hardy; Huw R Morris; Jacob Gratten; Peter M Visscher; Robert R Graham; Andrew B Singleton
Journal:  Lancet Neurol       Date:  2019-12       Impact factor: 44.182

7.  Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration.

Authors:  Jennifer Gass; Ashley Cannon; Ian R Mackenzie; Bradley Boeve; Matt Baker; Jennifer Adamson; Richard Crook; Stacey Melquist; Karen Kuntz; Ron Petersen; Keith Josephs; Stuart M Pickering-Brown; Neill Graff-Radford; Ryan Uitti; Dennis Dickson; Zbigniew Wszolek; John Gonzalez; Thomas G Beach; Eileen Bigio; Nancy Johnson; Sandra Weintraub; Marsel Mesulam; Charles L White; Bryan Woodruff; Richard Caselli; Ging-Yuek Hsiung; Howard Feldman; Dave Knopman; Mike Hutton; Rosa Rademakers
Journal:  Hum Mol Genet       Date:  2006-09-01       Impact factor: 6.150

8.  Evidence for GRN connecting multiple neurodegenerative diseases.

Authors:  Mike A Nalls; Cornelis Blauwendraat; Lana Sargent; Dan Vitale; Hampton Leonard; Hirotaka Iwaki; Yeajin Song; Sara Bandres-Ciga; Kevin Menden; Faraz Faghri; Peter Heutink; Mark R Cookson; Andrew B Singleton
Journal:  Brain Commun       Date:  2021-05-01

9.  RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data.

Authors:  Xiaowei Zhan; Youna Hu; Bingshan Li; Goncalo R Abecasis; Dajiang J Liu
Journal:  Bioinformatics       Date:  2016-02-15       Impact factor: 6.937

10.  Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.

Authors:  Ramita Dewan; Ruth Chia; Jinhui Ding; Richard A Hickman; Thor D Stein; Yevgeniya Abramzon; Sarah Ahmed; Marya S Sabir; Makayla K Portley; Arianna Tucci; Kristina Ibáñez; F N U Shankaracharya; Pamela Keagle; Giacomina Rossi; Paola Caroppo; Fabrizio Tagliavini; Maria L Waldo; Per M Johansson; Christer F Nilsson; James B Rowe; Luisa Benussi; Giuliano Binetti; Roberta Ghidoni; Edwin Jabbari; Coralie Viollet; Jonathan D Glass; Andrew B Singleton; Vincenzo Silani; Owen A Ross; Mina Ryten; Ali Torkamani; Toshiko Tanaka; Luigi Ferrucci; Susan M Resnick; Stuart Pickering-Brown; Christopher B Brady; Neil Kowal; John A Hardy; Vivianna Van Deerlin; Jean Paul Vonsattel; Matthew B Harms; Huw R Morris; Raffaele Ferrari; John E Landers; Adriano Chiò; J Raphael Gibbs; Clifton L Dalgard; Sonja W Scholz; Bryan J Traynor
Journal:  Neuron       Date:  2020-11-26       Impact factor: 18.688

View more
  1 in total

1.  Decreased Prosaposin and Progranulin in the Cingulate Cortex Are Associated with Schizophrenia Pathophysiology.

Authors:  Yachao He; Xiaoqun Zhang; Ivana Flais; Per Svenningsson
Journal:  Int J Mol Sci       Date:  2022-10-10       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.